1065837

Adam S. Giermasz, M.D., Ph.D. — FEI 3014583375

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Sacramento, CA (United States)

Additional Details

Clinical Investigator (CI)